Interestingly, the increased regulated intramembranous proteolysis of EpCAM resulting in release of its cytoplasmic domain, Ep-ICD in colon carcinoma and its subsequent translocation to the nucleus has been demonstrated to trigger oncogenic signaling [34]. Here, EPCAM is linked to colon carcinoma.